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Abstract
Background: InterVA is a widely disseminated tool for cause of death attribution using information from verbal
autopsies. Several studies have attempted to validate the concordance and accuracy of the tool, but the main
limitation of these studies is that they compare cause of death as ascertained through hospital record review or
hospital discharge diagnosis with the results of InterVA. This study provides a unique opportunity to assess the
performance of InterVA compared to physician-certified verbal autopsies (PCVA) and alternative automated
methods for analysis.
Methods: Using clinical diagnostic gold standards to select 12,542 verbal autopsy cases, we assessed the
performance of InterVA on both an individual and population level and compared the results to PCVA, conducting
analyses separately for adults, children, and neonates. Following the recommendation of Murray et al., we
randomly varied the cause composition over 500 test datasets to understand the performance of the tool in
different settings. We also contrasted InterVA with an alternative Bayesian method, Simplified Symptom Pattern
(SSP), to understand the strengths and weaknesses of the tool.
Results: Across all age groups, InterVA performs worse than PCVA, both on an individual and population level. On
an individual level, InterVA achieved a chance-corrected concordance of 24.2% for adults, 24.9% for children, and
6.3% for neonates (excluding free text, considering one cause selection). On a population level, InterVA achieved a
cause-specific mortality fraction accuracy of 0.546 for adults, 0.504 for children, and 0.404 for neonates. The
comparison to SSP revealed four specific characteristics that lead to superior performance of SSP. Increases in
chance-corrected concordance are attained by developing cause-by-cause models (2%), using all items as opposed
to only the ones that mapped to InterVA items (7%), assigning probabilities to clusters of symptoms (6%), and
using empirical as opposed to expert probabilities (up to 8%).
Conclusions: Given the widespread use of verbal autopsy for understanding the burden of disease and for setting
health intervention priorities in areas that lack reliable vital registrations systems, accurate analysis of verbal
autopsies is essential. While InterVA is an affordable and available mechanism for assigning causes of death using
verbal autopsies, users should be aware of its suboptimal performance relative to other methods.
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Verbal autopsy (VA) is increasingly being used in many
monitoring, surveillance, and research settings [1-6]. In
settings without complete vital registration and medical
certification of death, VA provides one of the only
methods for obtaining empirical information on cause
of death patterns. The main strategy for assigning causes
of death from data collected through a VA instrument is
through physician-certified verbal autopsy (PCVA)
[7-13]. Byass et al. proposed InterVA as an automated
alternative to PCVA [14,15]. InterVA, now in edition 3.2
[16], has been applied in a number of research and
demographic surveillance sites [14,17-25]. The method
is based on the logic of Bayes’ theorem. According to
Bayes’ theorem, prior views on the distribution of causes
of death for a population are updated by each symptom
response in the instrument. The probabilities of
responding yes to an item conditional on the true cause
of death have been developed through expert review
panels.
Several studies have investigated the validity of InterVA
as a tool for assigning causes of death [15,17,18]. A 2003
study analyzing 189 VA interviews in Vietnam found
that, when considering all three possible causes assigned
by the program, InterVA achieved over 70% concordance
using PCVA as a comparator [14]. In another study that
used InterVA to estimate AIDS deaths from 193 VA
interviews in Ethiopia, the model correctly assigned 82%
of AIDS deaths using hospital data as a gold standard
[17]. Lastly, a study in Kenya that examined 1,823 VA
interviews found 35% agreement between InterVA and
physician review cause assignments [26]. The main lim-
itation of these studies, as noted by several of the authors,
is that they compare cause of death as ascertained
through hospital record review or hospital discharge
diagnosis with the results of InterVA. In low-resource
and rural settings, where many of these studies have been
conducted, the quality of the hospital diagnosis itself is
often suspect. These studies provide information on the
nominal association between hospital-assigned cause of
death and InterVA, not true assessments of criterion
validity where there is a gold standard cause of death.
Further, comparison of InterVA with other published
automated methods such as direct cause-specific mortal-
ity fraction (CSMF) estimation [27] or the Symptom Pat-
tern Method [28] are limited by the reporting of different
metrics in these studies.
The Population Health Metrics Research Consortium
(PHMRC) provides an opportunity to assess the criter-
ion validity of InterVA in a large multisite study. The
PHMRC verbal autopsy study has been undertaken to
develop a range of new analytical methods for verbal
autopsy and to test these methods using data collected
in six sites in four countries (Mexico, Tanzania, India,
and the Philippines) [29]. The PHMRC study is unique
both in terms of the size of the validation dataset (7,836
adult deaths, 2,075 child deaths, and 2,631 neonatal
deaths) and the use of rigorously defined clinical diag-
nostic criteria for a death to be included in the study as
a gold standard cause of death. Although the study was
not originally designed to test the validity of InterVA,
the study provides a unique opportunity to assess the
performance of InterVA compared to PCVA and alter-
native automated methods for analysis.
Methods
The design, implementation, and general descriptive
results for the PHMRC gold standard VA validation
study are described elsewhere [29]. The final study
r e p o r t so n4 6a d u l tc a u s e so fd e a t h ,2 1c h i l dc a u s e so f
death, 10 neonatal causes of death, and stillbirths. Of
note for this study, gold standard cause of death assign-
ment was based on strict clinical diagnostic criteria
defined prior to data collection - level 1 diagnostic cri-
teria are stricter than level 2. Table 1 provides the num-
ber of adult, child, and neonatal deaths by cause (using
the joint cause list described below). For the analysis in
this paper, we present results pooling both level 1 and
level 2 gold standard causes of death. We conduct and
report on separate analyses for adult, child, and neonatal
deaths. Figure 1 provides a visual representation of the
overall approach of the methods.
Symptoms
InterVA version 3.2 is designed to have as input 106
items and yield predictions for 35 causes of death across
all ages. The PHMRC data collection was based on a
modification of the World Health Organization (WHO)
instrument for VA, and Additional files 1, 2 and 3 list the
PHMRC questions used to answer each InterVA item.
Because InterVA does not interpret missing data, items
n o tm a p p e df r o mt h eP H M R Cs u r v e yt ot h eI n t e r V A
items were input as negative responses in InterVA. We
extracted free text terms from open ended responses and
coded them as dichotomous variables as described in the
PHMRC study design paper [29]. Separate analyses were
run with and without free text responses, but their inclu-
sion had a negligible impact on the performance of the
tool. In addition to the 106 symptom inputs, InterVA
also uses priors for malaria and HIV/AIDS prevalence in
the region of the deceased. We used regional malaria and
HIV/AIDS prevalence as priors (see Additional file 4),
but conducted a separate analysis in which we used the
prevalence of a sample data draw as the priors. As we
expected, using the regional prevalence was superior to
using the draw prevalence.
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The PHMRC study included 46 causes for adults, 21
causes for children, 10 causes for neonates, and still-
births. For each observation, InterVA predicts up to
three causes of death from a list of 35 causes across all
age groups. We have mapped the InterVA cause list and
the PHMRC cause list into a set of mutually-exclusive,
collectively-exhaustive cause categories for each age
category. The details for this mapping are provided in
Additional files 5, 6 and 7. The resulting joint cause lists
contain 24 causes for adults, 18 causes for children, and
six causes for neonates.
As mentioned above, InterVA can produce up to three
potential causes for each death, and in some cases
assigns deaths an indeterminate cause. Table 2 shows
(by age group) the fraction of deaths to which InterVA
assigned exactly one, two, or three causes, and the frac-
tion deemed indeterminate. For modules reporting on
o n l yo n ec a u s ea s s i g n m e n t ,w eu s et h ef i r s tc a u s eo f
death to calculate chance-corrected concordance. We
have also separately computed chance-corrected concor-
dance using one, two, or all three InterVA cause
assignments.
For calculating accuracy, indeterminate deaths were
equally redistributed across the causes that InterVA had
predicted. Redistribution of indeterminate causes across
the other causes improves measured accuracy.
Multiple validation test sets
As recommended by Murray et al. for validation studies
[30], we vary the cause composition of the validation
dataset by creating 500 test datasets. To do this, we first
sample 500 distributions of CSMFs such that the sum of
the CSMFs across causes equals 1.0. This is implemen-
ted by sampling from an uninformative Dirichlet distri-
bution. We then randomly sample gold standard deaths
with replacement to generate a test dataset with the
desired CSMF composition. We then compute chance-
corrected concordance and CSMF accuracy for each
split (explained below). Because InterVA produces the
Table 1 Number of deaths for adults, children, and neonates by cause
Adult causes Deaths Child causes Deaths
Acute cardiac death 400 Chronic cardiac death 76
Chronic cardiac death 416 Chronic respiratory disease 12
Chronic respiratory disease 218 Diarrhea 256
Diabetes 414 Drowning 83
Diarrhea 228 HIV/AIDS 20
Disease of nervous system 49 Homicide 52
Drowning 106 Malaria 117
HIV/AIDS 501 Malignancy 28
Homicide 167 Measles 23
Kidney or urinary disease 413 Meningitis 99
Liver disease 313 Other acute infection 111
Malaria 100 Other digestive disease 48
Malignancy 1,090 Other injuries 171
Maternal Death 402 Other noncommunicable diseases 182
Other acute infection 263 Pneumonia/sepsis 678
Other digestive disease 166 Poisoning 18
Other injuries 464 Transport-related accident 92
Other noncommunicable diseases 200 Tuberculosis (pulmonary) 9
Pneumonia/sepsis 609 Total 2075
Poisoning 86
Stroke 630 Neonate causes Deaths
Suicide 124 Congenital malformation 250
Transport-related accident 202 Meningitis 6
Tuberculosis (pulmonary) 275 Perinatal asphyxia 461
Total 7836 Pneumonia/sepsis 250
Preterm/small baby 662
Total 1629
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were run through the InterVA interface only once, and
those cause assignments were used for the validation
analysis.
Metrics
Following the recommendations of Murray et al. [30],
we assess the performance of InterVA compared to the
gold standard using two types of metrics capturing the
Original Data with 
Validated Gold Standard
7836 Adult
2075 Child
1629 Neonate
Run all deaths 
through InterVA 
interface with 
region-specific 
prevalences
Create age-specific 
data files that have 
the InterVA-
assigned and gold 
standard causes
Map PHMRC survey 
items to InterVA 
items
Generate 500 
Dirichlet-sampled 
cause compositions
500 Test Draws
Sample, with 
replacement, using 
cause compositions 
(up to the size of the 
full dataset)
Map InterVA causes 
and PHMRC causes 
to a merged list:
Adult: 24
Child: 18
Neonate: 6
Calculate accuracy 
and chance-
corrected 
concordance for 
each draw
Calculate accuracy and 
chance-corrected 
concordance across 
draws
InterVA analysis, performed separately for each age group (adult, child, neonate)
Figure 1 Overview of analytical process. This figure is a visual representation of the steps necessary for analysis, performed separately for each
age group.
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mation. Assigning deaths to specific causes is assessed
using cause-specific chance-corrected concordance and
the average of cause-specific chance-corrected con-
cordance across causes. As noted, to assess whether the
second and third causes predicted for some deaths
by InterVA improve performance, we also compute
chance-corrected concordance incorporating the second
and third cause assignments. Performance predicting
CSMFs is assessed using CSMF accuracy, which is
scaled from zero to one, where zero is the maximum
possible error and one is no error in predicting CSMFs.
The relationship between predicted CSMFs and true
CSMFs across the 500 test datasets is summarized for
each cause by performing a regression of true CSMFs
on estimated CSMFs. Details on how to compute these
metrics are provided in Murray et al. [30].
Comparison to Simplified Symptom Pattern Method
Because we document poor performance of InterVA in
comparison to PCVA [31], we have also compared
InterVA to the Simplified Symptom Pattern (SSP)
Method [28,32]. SSP is also based on Bayes’ theorem;
however, there are four key differences between InterVA
and simplified SSP. First, the SSP Method develops Baye-
sian models for one cause compared to all other causes
at a time, while InterVA considers all causes indepen-
dently. Second, SSP uses the 40 most informative symp-
toms for each cause from the entire universe of all items
in the survey, while InterVA is limited to the items that
map to it (roughly one-third the number of inputs) and
uses all of these symptoms (regardless of how informative
they are). Third, SSP captures the interdependencies of
the symptom responses, while InterVA considers each
symptom individually. Finally, SSP uses empirical mea-
surements of the probability of a symptom set condi-
tional on the true cause captured in a training dataset,
while InterVA uses expert opinion. Using the PHMRC
data, we progressively change SSP to be more like
InterVA and assess its performance using chance-cor-
rected concordance and CSMF accuracy to understand
which aspects of InterVA lead to poor performance. We
analyzed three progressively changing permutations of
the SSP Method to identify the effect each difference
between SSP and InterVA had on the performances.
First, we developed an SSP model for all causes at once
rather than developing a model for each cause compared
to all other causes at a time. Second, we restricted the
universe of items available for SSP to only those used by
InterVA. Third, we force SSP to assume that each item
or symptom is independent of each other, as opposed to
clustering different symptoms and developing probabil-
ities of those combinations. Further details on SSP are
available in Murray et al. [32].
Results
Performance assigning true cause to individual deaths
Across-cause results
Table 3 reports median chance-corrected concordances
(across all causes) for one, two, and three cause assign-
ments. The results are shown separately for all age
groups, reporting on models with and without the inclu-
sion of free text variables. Across all age groups and
cause selections, the inclusion of free text variables at
most increases chance-corrected concordance by 1.3%.
The performance of InterVA, as measured by chance-
corrected concordance, was comparable for adults and
children using one cause selection (adults = 24.2%; chil-
dren = 24.9%). However, the tool performed substan-
tially worse for neonates, with a chance-corrected
concordance of 6.3%.
In all three age groups, consideration of the second
and third cause assigned by InterVA led to lower
chance-corrected concordance, compared to considera-
tion of only the first cause. This is largely due to the
fact that InterVA rarely predicts more than one cause
(at most 17% of cases).
Figure 2 shows the comparison overall for adults, chil-
dren, and neonates to PCVA as reported by Lozano et al.
[31] for the PHMRC gold standard datasets. For all three
age groups, InterVA has markedly lower chance-
corrected concordances. Interestingly, the performances
of InterVA and PCVA follow the same pattern, doing
best in children by a small margin, followed by adults,
and performing less well for neonates.
Cause-specific results
Additional file 8 shows the chance-corrected concor-
dance, by cause, for adults, children, and neonates.
These figures were calculated without the use of free
text variables, and only considered the first InterVA
cause assignment. These tables illustrate the distribution
of InterVA’s performance across causes.
For both adults and children, InterVA performed quite
well for transport-related deaths; the chance-corrected
Table 2 Percent of deaths assigned to particular cause numbers by InterVA
Exactly one assignment Exactly two assignments Exactly three assignments Indeterminate
Adult 80.3% 16.1% 1.9% 1.8%
Child 76.7% 17.9% 1.9% 3.5%
Neonate 96.8% 2.6% 0.0% 0.5%
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dren. InterVA also did well on some other injuries,
including its high chance-corrected concordance for poi-
soning (58.9%) and drowning (55.8%) in children. For
adults, chance-corrected concordance was higher than
50% for homicide, liver disease, and tuberculosis, with
nearly 50% for malignancy and maternal deaths. For
children, in addition to the aforementioned injuries,
InterVA had chance-corrected concordances of close to
50% for pneumonia/sepsis and HIV/AIDS. For neonates,
the only cause with a chance-corrected concordance
over 50% was perinatal asphyxia (77.4%).
While InterVA performed well for some causes such
as these selected injuries, there were a number of causes
that InterVA struggled to predict accurately. For adults,
the lowest chance-corrected concordances were for dis-
ease of the nervous system (-4.3%), and the residual
category other noncommunicable diseases (-4.0%). For
children, InterVA struggled to accurately assign indivi-
dual deaths for a number of categories. Similarly to
adults, InterVA had poor performance with residual
categories such as other acute infection and other diges-
tive disease, with chance-corrected concordances of
-5.9% for both causes. Chance-corrected concordance
was also low for diseases that are rare in children, such
as chronic cardiac death and malignancies. For neonates,
InterVA did not perform well for a series of causes.
Again, we saw the lowest chance-corrected concordance
for the rarest cause (meningitis = -25.0%). Congenital
malformation was another neonatal cause for which
InterVA performed poorly, with a chance-corrected con-
cordance of -12.9%.
Performance estimating CSMFs
CSMF accuracy
Table 4 reports median CSMF accuracy (across all
causes) for one, two, and three cause assignments. The
results are shown separately for all age groups, reporting
on models with and without the inclusion of free text
variables. Across all age groups and cause selections, the
inclusion of free text variables at most increases accu-
racy by 0.016. The performance of InterVA was compar-
able for adults and children, with an accuracy of 0.546
for adults and 0.504 for children. However, the tool per-
formed substantially worse for neonates, with an accu-
racy of 0.404.
In all three age groups, consideration of the second
and third cause assigned by InterVA had a negligible
effect on accuracy, with a maximum difference of 0.017.
While the consideration of multiple cause assignments
had a detrimental effect on chance-corrected concor-
dance, that relationship was not seen for accuracy. This
implies that, at the population level, the second and
third cause assignments are as accurate as the first.
Figure 3 summarizes CSMF accuracy for the three age
groups and provides benchmark comparisons for PCVA
as reported by Lozano et al. [31] for the same PHMRC
gold standard database. In all age groups, CSMF accu-
racy is substantially lower than that observed for PCVA.
Interestingly, InterVA performs better for older age
groups, while PCVA performs better for younger age
groups.
True versus estimated CSMFs
Figure 4 shows the results of regressing the true CSMF
on the estimated CSMF for four selected adult causes
(Additional file 9 shows the results for all causes for
Table 3 Median chance-corrected concordance (%) across causes for one, two, and three cause assignments (95%
uncertainty interval [UI])
Age Module One cause Two causes Three causes
Adult Free text 25.2 (25.1, 25.3) 25.1 (25.0, 25.1) 21.7 (21.6, 21.8)
No free text 24.2 (24.1, 24.3) 24.0 (23.9, 24.1) 20.6 (20.5, 20.7)
Child Free text 25.0 (24.7, 25.2) 22.5 (22.3, 22.7) 17.5 (17.3, 17.7)
No free text 24.9 (24.7, 25.0) 21.4 (21.3, 21.7) 16.2 (16.1, 16.4)
Neonate Free text 6.5 (6.2, 6.7) -22.3 (-22.6, -22.0) N/A
No free text 6.3 (6.1, 6.5) -22.8 (-23.0, -22.5) N/A
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
50.0%
Adult Child Neonate
C
h
a
n
c
e
-
C
o
r
r
e
c
t
e
d
 
C
o
n
c
o
r
d
a
n
c
e
 
InterVA
PCVA
Figure 2 Median chance-corrected concordance of InterVA and
PCVA. This figure compares the performance of InterVA with PCVA
across 500 Dirichlet draws. PCVA performs better than InterVA for all
age groups.
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put has a distinct implication for the relationship
between true and estimated CSMFs. The ideal slope
should be 1.00, such that a unit increase in the true
CSMF corresponds to an equal unit increase in the esti-
mated CSMF. The ideal intercept value is 0.00, and
deviation from this provides information regarding the
performance of the tool in populations with small cause
fractions for that particular disease. Finally, the root
mean squared error (RMSE) gives a measure of the
uncertainty in the estimated CSMFs.
The causes selected for Figure 4 were chosen to
demonstrate the differential performances of InterVA
across causes. Both homicide and maternal death pro-
vide examples in which near-zero intercepts, 0.014 and
0.009 respectively, indicate good performance in sample
populations with small cause fractions. However, in
both instances, a slope that deviates substantially from
1.00 implies that InterVA will underestimate the propor-
tion of these causes in populations where the disease is
common. The low RMSEs (≤.006) indicate that the
underestimation is consistent across different simulated
populations, and may be amenable to a post hoc correc-
tion. Pneumonia/sepsis and HIV/AIDS provide examples
in which the cause fractions are overestimated in draws
with low cause fractions. With large intercepts, 0.160
and 0.082 respectively, InterVA predicts the presence of
these conditions even if they are virtually absent in the
population. Finally, higher RMSE values (> 0.01) suggest
that correcting for this overestimation will be more diffi-
cult than correcting for the underestimation of homicide
or maternal deaths.
Comparison to SSP variants
Figure 5 shows a comparison of InterVA median
chance-corrected concordance across causes with CSMF
accuracy compared to three variants of SSP applied to
the same dataset. Prior to modification, the SSP method
had a chance-corrected concordance of 48% and an
accuracy of 0.73. The first variant of SSP involved devel-
oping a model for all causes at once, rather than cause-
by-cause models. This lowered chance-corrected concor-
d a n c eb y2 %a n da c c u r a c yb y0 . 0 2 .T h es e c o n dv a r i a n t
further modified the methods by only using the survey
questions that mapped to the InterVA survey. This low-
ered the chance-corrected concordance an additional 7%
and lowered accuracy an additional 0.04. In addition to
these changes, the third variation of SSP assumes the
responses to each symptom are independent, as opposed
to using clusters of symptoms that allow for correlation
between items in response patterns. This method low-
ered the chance-corrected concordance by 6%, resulting
in an overall chance-corrected concordance of 33% and
an accuracy of 0.60. As SSP is modified to become more
like InterVA, its performance both in terms of chance-
corrected concordance and accuracy steadily declines.
Figure 6 shows a comparison of selected empirical
probabilities of SSP to the expert probabilities of
InterVA for the symptom acute cough. This graph illus-
trates some of the differences in the prior probabilities
of selected causes, which, based on the above analysis,
may account for up to 8% chance-corrected concor-
dance and 0.05 accuracy. Of note, InterVA tends to
have higher probabilities than SSP for causes that are
unrelated to cough (drowning, suicide, maternal death),
while SSP has a higher probability for related causes
such as infections and chronic respiratory disease.
Table 4 Median CSMF accuracy across 500 Dirichlet draws, by age group and number of cause assignments (95% UI)
Age Module One cause Two causes Three causes
Adult Free text 0.549 (0.542, 0.557) 0.555 (0.548, 0.563) 0.556 (0.548, 0.564)
No free text 0.546 (0.539, 0.553) 0.554 (0.548, 0.560) 0.555 (0.549, 0.561)
Child Free text 0.520 (0.513, 0.528) 0.503 (0.495, 0.511) 0.503 (0.496, 0.512)
No free text 0.504 (0.496, 0.514) 0.487 (0.480, 0.494) 0.487 (0.482, 0.496)
Neonate Free text 0.405 (0.392, 0.420) 0.409 (0.397, 0.425) N/A
No free text 0.404 (0.388, 0.419) 0.407 (0.393, 0.423) N/A
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Figure 3 Median CSMF accuracy of InterVA and PCVA.T h i s
figure compares the performance of InterVA with PCVA across 500
Dirichlet draws. It shows a substantially better performance for PCVA
than InterVA for all age groups.
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This assessment of the performance of InterVA compared
to gold standard cause of death assignment in a large mul-
tisite study shows an overall chance-corrected concor-
dance of 24.2%, 24.9%, and 6.3% for adults, children, and
neonates, respectively. At the level of estimating CSMFs,
InterVA has a CSMF accuracy of 0.546 for adults, 0.504
for children, and 0.404 for neonates. Compared to PCVA,
the performance of InterVA is much lower in terms of
chance-corrected concordance, and it produces substan-
tially larger errors in estimated CSMFs [31].
The poor performance of InterVA, given some pub-
lished studies, is surprising. Not all studies, however,
have reported good concordance. Oti et al. [33] com-
pared InterVA on 1,823 deaths to physician review and
found a chance-corrected concordance of 31.2%, which is
not much higher than reported here - authors’ calcula-
tions. One other validation study found a 33.3% chance-
corrected concordance when comparing InterVA to phy-
sician review [14]. Two factors may account for the
difference in the findings here compared with the more
favorable studies. First, the PHMRC database is the first
VA validation study where cause of death has been
assigned using strict clinical diagnostic criteria and not
medical record review or hospital diagnosis. The distinc-
tion is critical; in medical record review a chart may say
myocardial infarction but not have documentation on
how this diagnosis was made. In the PHMRC dataset, a
death from myocardial infarction requires at least one of
the following: cardiac perfusion scan, electrocardiogram
changes, documented history of coronary artery bypass
grafting or percutaneous transluminal coronary angio-
plasty or stenting, coronary angiography, and/or enzyme
changes in the context of myocardial ischemia. Second, it
is difficult to compare across previous studies because
different metrics and results are reported for only one
CSMF composition in the test data. Murray et al. report
that findings can vary widely as a function of CSMF com-
position, and therefore metrics based on a single CSMF
can be highly misleading [30].
Est=.160 + 165 True  
RMSE=.019
Est=.014 + .533 True 
RMSE=.006
Est=.009 + .490 True 
RMSE=.002
Est=.082 + .332 True 
RMSE=.011
Figure 4 Estimated versus true CSMFs. This figure shows scatter plots of the estimated CSMF versus the true CSMF for pneumonia/sepsis,
homicide, maternal death, and HIV/AIDS across 500 Dirichlet draws. It demonstrates the performance of InterVA for four causes of death as the
cause fractions vary. Each graph shows the results from a regression of true CSMF on estimated CSMF, as well as the root mean squared error.
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sion results of CSMF true on CSMF estimated for each
cause provides a framework for analyzing the strengths
and weaknesses of InterVA. Clearly, the program is cur-
rently better suited to identify certain more obvious
causes than other more complex ones. The program
also has differential performances based on the cause
fraction of each disease. This partly explains why
different studies have shown different levels of accuracy
for the program. InterVA could easily identify deaths
with highly-probable symptoms such as road traffic inju-
ries, but it struggled with less explicit causes such as
infections. There also appeared to be some anomalous
results from the program. For example, the program
indicates that the probability of assigning drowning as a
true cause is 0.99 if the respondent responded “yes” to
the question “did s/he drown?” However, of the 117
adult deaths in which the respondent indicated that
there was drowning, InterVA only assigned six of them
“drowning” as the cause of death. We believe that this
was the result of a coding error in the program. InterVA
also tends to overpredict perinatal asphyxia in neonates.
While we are less confident why this is, we believe that
it is a notable shortcoming of the program. We hope
that the cause-specific results can be used to better
inform expert priors for future Bayesian methods.
The analysis of InterVA compared to the other Baye-
sian automated approach, Simplified Symptom Pattern,
also provides a clear indication of why InterVA is not
working well. The analysis of SSP variants designed to
approximate InterVA show that four factors contribute
to better results using SSP: use of interdependencies in
the symptom responses, the use of all the items in the
WHO or PHMRC instrument rather than just the 106
items in InterVA, the use of empirical probabilities of
symptoms conditional on the true cause rather than
expert judgment, and finally the technical advantage of
developing models for each cause relative to other
causes rather than all causes independently [32]. Moving
to empirical probabilities improved chance-corrected
concordance by 4%, capturing the interdependencies of
some items added another 6%, and expanding from the
InterVA item list to the full item list added another 7%.
The progressive improvement in the performance of the
SSP variants provides an understanding of how the lim-
itations of the implementation of Bayes’ theorem in
InterVA contribute to its poor performance.
There are several limitations of this study. First,
because the InterVA and PHMRC cause lists had to be
merged to a joint cause list, InterVA was essentially
challenged to predict causes that it was not built to
identify (such as specific types of injuries). Conversely,
there are a number of causes for which InterVA may
predict very well that were not included in the study
(such as malnutrition in children). InterVA could in the-
ory perform well for these causes, which would have
increased its average chance-corrected concordance.
Note that the cause list used for the assessment of
PCVA performance was slightly longer, so the InterVA
performance may have been slightly exaggerated [31].
Second, there were a number of InterVA items that
were not mapped to the PHMRC survey (17 adult
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Page 9 of 11questions, 32 child questions, and 30 neonatal ques-
tions). Inclusion of these items would likely improve
performance of the tool. Third, InterVA predicted
deaths in some age groups for causes that largely belong
to other age groups. For example, it predicted preterm/
small baby as a child cause and malnutrition as an adult
cause. These deaths were assigned to the residual other
category. This practice also may have exaggerated
InterVA accuracy.
The contribution of this study is the use of gold stan-
dard cases for the validation of InterVA. The aforemen-
tioned studies only provide information on the
relationship between InterVA and hospital- assigned or
physician-reviewed cause of death. This study provides a
direct comparison of InterVA to gold standard verified
causes of death. It is also important to note that this
s t u d yi sc o n s i d e r i n gt h ep e r f o r m a n c eo fI n t e r V Ai na
diverse cultural and epidemiological context. However,
further analysis from each of the sites will provide speci-
fic results about the performance of InterVA in each of
the countries included in the PHMRC study.
Conclusions
This study demonstrated both the strengths and weak-
nesses of InterVA as a method of assessing both indivi-
dual-level and population-level causes of death. For the
first time, the use of gold standards for validation illus-
trates the performance of the tool in diverse settings. To
date, InterVA has proven popular with some users
because it is automated and can reduce the cost of VA
analysis and speed up data processing. InterVA does not
use free text items and implicitly encourages users to use
structured instruments that may also lead to savings and
efficiencies in data processing. The relative computa-
tional simplicity of InterVA also means that it can work
in a variety of settings without access to more sophisti-
cated computational power that might be required for
some empirically-derived methods. Additionally, InterVA
is not linked to a specific VA instrument, which is both a
strength and a weakness. The strength is that, in princi-
ple, it can be used to analyze data collected historically
with different or more limited instruments. The weak-
ness, however, is that much of the salient information
collected in the WHO or PHMRC instruments are not
used. Further, because it is not tied to an instrument, the
InterVA items are defined in medical terms and are not
actually mapped to particular questions that can be asked
of households. Such ambiguity stems from the specifica-
tion of the InterVA variables as medical terms rather
than VA instrument items.
These advantages come at a substantial decrement in
performance compared to PCVA. Fortunately, other
automated options for the analysis of VA data have the
same advantages but have validated performance equal
to or better than PCVA, such as the Tariff Method, SSP,
and machine learning [32,34,35]. Given the widespread
use of VA for understanding the burden of disease and
setting health intervention priorities in areas that lack
reliable vital registrations systems, accurate analysis of
VAs is essential. Until InterVA is substantially revised,
users should carefully consider the use of alternative
automated approaches for the analysis of VA data.
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